Your responses are somewhat confusing to me. As

New Post Public Reply Private Reply Replies (1) Message Board
blafarm chessmaster #53413
858
Your responses are somewhat confusing to me.

As mentioned, I am always happy to be corrected, that's how I learn and grow, but let's take a moment and unpack your responses.

You Wrote:
Quote:
This statement is FALSE without clarification ...

The clock is absolutely not reset toward the PDUFA date because they have a rolling review. Now if you mean reset with respect to them responding for a PDUFA date I will give you that

My Response:
I don't understand the distinction you are making. How does a "clock not reset toward the PDUFA date" -- differ from a clock "reset with respect to them responding for a PDUFA date"?

Did you take the time to read the "FDA: CDER 21st Century Review Process" document that I clearly linked in my post?

https://www.fda.gov/media/78941/download

Allow me to provide you with an excerpt from page 20:
Quote:
A refusal-to-file decision ends the review process. The applicant’s options are to resubmit the NDA/BLA with the deficiencies addressed (the resubmission is considered an original new application) or to request that the NDA/BLA be filed over protest. PDUFA V “Program” applications that are subsequently filed over protest are removed from “The Program” and become subject to the standard 6- or 10-month review clock, as applicable.
Please provide clarification.

You Wrote:
Quote:
Now wouldnt this be a HUGE question to ask on the conference call? I hope someone reads this and asks.

My Response:
If my statement is "absolutely" "FALSE" as you contend, then why does this question need to be asked? You obviously already know the answer, and if you don't, why don't you simply ask the question yourself during the call?

You Wrote:
Quote:
This frustrates me that so many are uninformed. The only way to clear this up is to ask the question on the conference call. What impact has the RTF had on the PDUFA date? Will the clock reset to another 6 months.

My Response:
You seem to be saying that you don't know the answer either -- as you want the company to clear up this question on the conference call. So then, you and I are maybe both "uninformed".

You Wrote:
Quote:
They will have to say it could but it wont because 2/3rds of the Rolling review are theoretically going on right now so when they get the last submission they have very little left to review. We are weeks to months away from THE PDUFA date. It will likely be this year but I honestly dont think that we will ever find out because I expect drug approval before then and then HIV can be the label extension.

My Response:
I don't know quite how to process this. You seem to be saying that the company will have to "say it", but regardless of what the company says, the clock "wont [be reset] because 2/3rds of the Rolling review are theoretically going on right now so when they get the last submission they have very little left to review."

I think you'd have to agree, there's quite a bit of tension in that statement. You seem to be asserting that it doesn't make a difference what the company says -- the clock will abide by your own understanding of how the universe works.

You Wrote:
Quote:
We are weeks to months away from THE PDUFA date. It will likely be this year but I honestly dont think that we will ever find out because I expect drug approval before then and then HIV can be the label extension.

My Response:
Since you contend my statement is "absolutely" "FALSE", which is it, are we weeks away or months away? I'm assuming you know the answer to this question.

Also, do you really believe: "I honestly dont think that we will ever find out"? In other words, do you really believe we will never learn this information?


Final Thoughts:
I began my post with this sentence:

"Happy to be corrected, but here is my understanding of the process."

I tend to chose my words carefully, so you can believe me when I said that I was "happy to be corrected".

Like many government agencies, the FDA's regulatory documents can be vague and confusing for laypersons to interpret and comprehend. I've invested time reading more documents than I care to remember in an effort to understand the moving parts of this process -- but I'm not perfect.

I may have possibly included an incorrect data point in my post. And I previewed this very real possibility when I wrote that I would be "happy to be corrected".

I have nothing against you, and I would be happy to be corrected by you. However, your responses don't exactly instill confidence that you know any more than I do.

And if that's the case, you might consider not accusing someone of making an "absolutely" "FALSE" statement unless you can clearly articulate the correct answer.

Again, I am happy to corrected as we all want to know the answer to this question.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Cracking the Code of America's Delivery Addiction

Updated Category News Views 4

America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 5

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 3

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading

Top 5 Most Recently Viewed Articles

Costco's Core Comps Show Signs of Cooling but Trends Remain Strong

Updated Category News Views 210

Overview of Recent Sales Trends at Costco Costco Wholesale Corp. (NASDAQ: COST) is currently under the spotlight as its November U.S. core sales reportedly fell short of expectations, hinting at a rare slowing of the company’s ongoing momentum. This dip arrives at a crucial time as consumers gear up for the holiday season, bringing fresh debates regarding overall...

Continue Reading
Ember Partners to Create Unique Luxury Co-Ownership at Lake Powell

Updated Category News Views 115

New Partnership for Luxury Co-Ownership A new era of luxury vacation experiences is upon us as Ember joins with Ascend at Lake Powell to redefine property management and ownership. This collaboration brings forth not just a vacation property but a lifestyle choice that caters to the adventurers at heart. This emerging resort townhome community invites residents to...

Continue Reading
New Competing Offer for Religare's Stake Creates Tensions

Updated Category News Views 254

New Developments in Religare's Ownership Battle In a surprising turn of events, India's Religare Enterprises (NSE: RELG) has announced that a U.S. businessman has stepped into the fray with a proposal to secure a 26% stake. This development adds yet another layer of complexity to the ongoing struggle for control over the financial services company, especially following...

Continue Reading
Exploring the Impressive Growth of Insulet Stock Over 15 Years

Updated Category News Views 156

Insulet's Market Performance Insulet (NASDAQ: PODD) has emerged as a standout performer in the stock market arena over the past 15 years. With an annualized return of 23.21%, Insulet has outpaced the broader market by an astonishing 10.41%. Today, the company boasts a market capitalization of approximately $22.62 billion, a testament to its rapid growth and investor...

Continue Reading
UTSA and UT Health San Antonio Join Forces for Better Impact

Updated Category News Views 305

UTSA and UT Health San Antonio Merger Overview In a significant step for higher education, UTSA and The University of Texas Health Science Center at San Antonio have merged, resulting in the formation of The University of Texas at San Antonio (UT San Antonio). This new institution emerges as the third-largest public research university in Texas, following prestigious...

Continue Reading